Clinical outcome of lung transplantation for chronic thromboembolic pulmonary hypertension
LT is an effective treatment for end-stage CTEPH, which can improve cardiopulmonary function and quality of life and prolong survival. Patients who are unable to tolerate PEA should be considered for LT as early as possible when internal medicine failed.
Authors
- Jintao Zhou
- Chen Yuan (ORCID: https://orcid.org/0000-0002-0708-9648)
- Shugao Ye (ORCID: https://orcid.org/0009-0009-5547-2594)
- Dian Xiong (ORCID: https://orcid.org/0000-0002-8905-9046)
- Jingyu Chen (ORCID: https://orcid.org/0000-0002-2127-1788)
- Jialong Liang
- Jian Xu (ORCID: https://orcid.org/0000-0003-2032-251X)
- Qian Li (ORCID: https://orcid.org/0009-0005-2437-6779)
- Huachi Jiang
Institutions
- Wuxi Taihu Hospital (CN)
- Wuxi People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s12890-024-03213-4
- Citations
- 3
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- National Natural Science Foundation of China